Table 6.
Direct cost (test and treatment cost) and comprehensive cost (including estimate of life value) of the presumptive versus the test based strategy at "ideal" adherence levels to both strategies: test and treatment cost subsidized (see text)
| Variables | Children, dry season | Children, rainy season | Adults, dry season | Adults, rainy season |
|---|---|---|---|---|
| Direct cost, presumptive strategy | 264 | 257 | 608 | 608 |
| Direct cost, test-based strategy | 209 | 247 | 485 | 516 |
| Comprehensive cost, presumptive strategy | 978 | 596 | 1330 | 1164 |
| Comprehensive cost, test-based strategy | 828 | 697 | 782 | 752 |
| Threshold life value* | n.a. (pres. dominated) | 44 | n.a. (pres. dominated) | n.a. (pres. dominated) |
Costs expressed in € (euro) for 1000 patients managed with either strategy, assuming a life value of 525 € (better option in bold)
* Life value at which the two strategies become equivalent at sensitivity analysis